Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma

Show other versions (1)

Metastatic renal cell carcinoma (RCC) seems to be resistant to conventional chemo- and radiotherapy and the general treatment regimen of cytokine therapy produces only modest responses while inducing severe side effects. Nowadays standard of care is the treatment with VEGF-inhibiting agents or mTOR...

Full description

Bibliographic Details
Main Authors:	Clara E. Jäkel, Stefan Hauser, Sebastian Rogenhofer, Stefan C. Müller, P. Brossart, Ingo G. H. Schmidt-Wolf
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2012/473245

Similar Items

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
by: Ying Zhang, et al.
Published: (2020-09-01)

Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells
by: Rombo, Roman, et al.
Published: (2016-04-01)

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors
by: Clara E. Jäkel, et al.
Published: (2014-01-01)

Cytokine-induced killer cells are type II natural killer T cells
by: Schmidt-Wolf, Ingo G.H., et al.
Published: (2007-09-01)

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
by: Francesca Garofano, et al.
Published: (2019-09-01)

Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide
by: Brossart, Peter, et al.
Published: (2009-06-01)

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
by: Mojgan Naghizadeh Dehno, et al.
Published: (2020-04-01)

High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells
by: Francesca Garofano, et al.
Published: (2020-05-01)

Increased Efficacy of Brentuximab Vedotin (SGN-35) in Combination with Cytokine-Induced Killer Cells in Lymphoma
by: Laura Esser, et al.
Published: (2016-07-01)

Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies
by: Yang Yang, et al.
Published: (2021-01-01)

Efficacy of cytokine-induced killer therapy following operation of renal cell carcinoma in north China
by: Jiaju Lv, et al.
Published: (2020-12-01)

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
by: Xiaolong Wu, et al.
Published: (2020-07-01)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
by: Frederic Carsten Schmeel, et al.
Published: (2014-08-01)

Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells
by: Claudia Schlimper, et al.
Published: (2012-01-01)

Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
by: Schöttker, Björn, et al.
Published: (2011-01-01)

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
by: Hansong Du, et al.
Published: (2020-04-01)

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
by: Ma Yue, et al.
Published: (2012-04-01)

Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies
by: Gianfranco ePittari, et al.
Published: (2015-05-01)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
by: Liu Y, et al.
Published: (2017-03-01)

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy
by: Michael Nowak, et al.
Published: (2011-09-01)

Cytokine regulation of natural killer cell activation and homeostasis /
by: Cooper, Megan Anne.
Published: (2002)

The role of cytokine in regulation of the natural killer cell activity
by: Jurišić Vladimir, et al.
Published: (2008-01-01)

Developmental and Functional Control of Natural Killer Cells by Cytokines
by: Yang Wu, et al.
Published: (2017-08-01)

Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells
by: Melanie Bremm, et al.
Published: (2019-05-01)

Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-Small Cell Lung Cancer
by: Zibing Wang, et al.
Published: (2018-07-01)

Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis
by: Zhou X, et al.
Published: (2018-11-01)

Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
by: Xingchun Gao, et al.
Published: (2017-07-01)

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
by: Dario Sangiolo
Published: (2011-01-01)

Uterine natural killer cells and related cytokines in reproductive failure
by: Mariee, Najat Girera
Published: (2011)

Dendritic cell derived cytokines in human natural killer cell differentiation and activation
by: Obinna eChijioke, et al.
Published: (2013-11-01)

Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells
by: Qingming Guo, et al.
Published: (2017-03-01)

Characterization of the natural killer cell cytokine response to antibody-coated tumor cells
by: Parihar, Robin
Published: (2004)

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
by: Xiaolong Wu, et al.
Published: (2021-10-01)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
by: Silvia Gaggero, et al.
Published: (2021-01-01)

Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets
by: Nathan G. F. Leborgne, et al.
Published: (2020-11-01)

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma
by: Marcin Kortylewski, et al.
Published: (2021-03-01)

Proteomic methods applied to renal cell carcinomas
by: Spandidos, Athanasia
Published: (2002)

Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
by: Schmiedel, Alexandra, et al.
Published: (2006-02-01)

Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma
by: Wen-Shin Chang, et al.
Published: (2019-03-01)

Establishment of Adoptive Immunotherapy Transfusion Time of Cytokine-induced Killer Cells
by: Changping Wu, et al.
Published: (2013-09-01)

Cannot write session to /tmp/vufind_sessions/sess_n2o57jgc7s77ionimtctauh39h